1887

Abstract

Recombination is one of the mechanisms by which viral genomes evolve. A vaccine-derived multirecombinant poliovirus strain was isolated from a 5-month-old child with vaccine-associated paralytic poliomyelitis after oral poliovirus vaccine administration. The isolate had an S2/S1/S2/S1 primary genomic structure as revealed by restriction fragment length polymorphism and sequencing analysis. Recombination of the middle S1/S2 region is extremely rare and one of the few characterized types of recombination with Sabin type 1 as a 5′ partner. An attempt was made to perform evolutionary analysis of the contributing sequences using the identified mutations in comparison with the original Sabin sequences. A hypothesis is proposed for the order in which the identified recombination events occurred.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80823-0
2005-11-01
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/11/3137.html?itemId=/content/journal/jgv/10.1099/vir.0.80823-0&mimeType=html&fmt=ahah

References

  1. Agol, V. I. ( 1997; ). Recombination and other genomic rearrangements in picornaviruses. Semin Virol 8, 77–84.[CrossRef]
    [Google Scholar]
  2. Bellmunt, A., May, G., Zell, R., Pring-Akerblom, P., Verhagen, W. & Heim, A. ( 1999; ). Evolution of poliovirus type I during 5·5 years of prolonged enteral replication in an immunodeficient patient. Virology 265, 178–184.[CrossRef]
    [Google Scholar]
  3. Blomqvist, S., Bruu, A. L., Stenvik, M. & Hovi, T. ( 2003; ). Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol 84, 573–580.[CrossRef]
    [Google Scholar]
  4. Blomqvist, S., Savolainen, C., Laine, P., Hirttio, P., Lamminsalo, E., Penttila, E., Joks, S., Roivainen, M. & Hovi, T. ( 2004; ). Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol 78, 4876–4883.[CrossRef]
    [Google Scholar]
  5. Casas, I., Powell, L., Klapper, P. E. & Cleator, G. M. ( 1995; ). New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 53, 25–36.[CrossRef]
    [Google Scholar]
  6. Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R. & Delpeyroux, F. ( 2001; ). Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol 75, 5740–5751.[CrossRef]
    [Google Scholar]
  7. Domingo, E. & Holland, J. J. ( 1997; ). RNA virus mutations and fitness for survival. Annu Rev Microbiol 51, 151–178.[CrossRef]
    [Google Scholar]
  8. Drake, J. W. & Holland, J. J. ( 1999; ). Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96, 13910–13913.[CrossRef]
    [Google Scholar]
  9. Driesel, G., Diedrich, S., Kunkel, U. & Schreier, E. ( 1995; ). Vaccine-associated cases of poliomyelitis over 30 year period in East Germany. Eur J Epidemiol 11, 647–654.[CrossRef]
    [Google Scholar]
  10. Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M. & Agol, V. I. ( 2000; ). Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74, 7381–7390.[CrossRef]
    [Google Scholar]
  11. Georgescu, M. M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Combiescu, A. A., Guillot, S. & Crainic, R. ( 1994; ). High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol 68, 8089–8101.
    [Google Scholar]
  12. Georgescu, M. M., Delpeyroux, F. & Crainic, R. ( 1995; ). Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J Gen Virol 76, 2343–2348.[CrossRef]
    [Google Scholar]
  13. Georgescu, M. M., Balanant, J., Ozden, S. & Crainic, R. ( 1997; ). Random selection: a model for poliovirus infection of the central nervous system. J Gen Virol 78, 1819–1828.
    [Google Scholar]
  14. Georgopoulou, A. & Markoulatos, P. ( 2001; ). Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes. Eur J Clin Microbiol Infect Dis 20, 792–799.[CrossRef]
    [Google Scholar]
  15. Georgopoulou, A., Markoulatos, P., Spyrou, N. & Vamvakopoulos, N. C. ( 2000; ). Improved genotyping of vaccine and wild type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications. J Clin Microbiol 141, 1047–1054.
    [Google Scholar]
  16. Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F. & Crainic, R. ( 2000; ). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74, 8434–8443.[CrossRef]
    [Google Scholar]
  17. Karakasiliotis, I., Markoulatos, P. & Katsorchis, T. ( 2004; ). Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees. Mol Cell Probes 18, 103–109.[CrossRef]
    [Google Scholar]
  18. Kew, O., Morris-Glasgow, V., Landaverde, M. & 21 other authors ( 2002; ). Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356–359.[CrossRef]
    [Google Scholar]
  19. Khetsuriani, N., Prevots, D. R., Quick, L., Elder, M. E., Pallansch, M., Kew, O. & Sutter, R. W. ( 2003; ). Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis 188, 1845–1852.[CrossRef]
    [Google Scholar]
  20. Li, W. H., Wu, C. I. & Luo, C. C. ( 1985; ). A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol Biol Evol 2, 150–174.
    [Google Scholar]
  21. Liu, H. M., Zheng, D. P., Zhang, L. B., Oberste, M. S., Pallansch, M. A. & Kew, O. M. ( 2000; ). Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74, 11153–11161.[CrossRef]
    [Google Scholar]
  22. Liu, H. M., Zheng, D. P., Zhang, L. B., Oberste, M. S., Kew, O. M. & Pallansch, M. A. ( 2003; ). Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol 77, 10994–11005.[CrossRef]
    [Google Scholar]
  23. MacLennan, C., Dunn, G., Huissoon, A. P. & 9 other authors ( 2004; ). Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363, 1509–1513.[CrossRef]
    [Google Scholar]
  24. Rezapkin, G. V., Chumakov, K. M., Lu, Z., Ran, Y., Dragunsky, E. M. & Levenbook, I. S. ( 1994; ). Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 202, 370–378.[CrossRef]
    [Google Scholar]
  25. Rezapkin, G. V., Fan, L., Asher, D. M., Fibi, M. R., Dragunsky, E. M. & Chumakov, K. M. ( 1999; ). Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Virology 258, 152–160.[CrossRef]
    [Google Scholar]
  26. Vinje, J., Gregoricus, N., Martin, J. & 11 other authors ( 2004; ). Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola. J Infect Dis 189, 1168–1175.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80823-0
Loading
/content/journal/jgv/10.1099/vir.0.80823-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error